Skip to main content
. 2016 Dec 8;176(2):173–181. doi: 10.1007/s00431-016-2819-2

Table 3.

Cost-analysis (Euro)

Intervention (N = 113) Usual care (N = 109)
Cost price Volume Costs Volume Costs
CDSS
 Development (h) 36 144 5184
Implementation
 Researcher (h) 54 4 216
 Nurse (number × h) 40 20 × 2 1600
 Total costs CDSS implementation 7000
ED visit
 Physician (h × visit number) 68 0.33 × 113 2535 0.33 × 109 2445
 Nurse (h × visit number) 40 0.5 × 113 2260 0.5 × 109 2180
 Hospital costs 114 113 12,882 109 12,426
Diagnostics
 Electrolytes 3.8 15 57 23 87
 Acid-base balance 5.10 13 66 16 82
Treatment
 Unknown 6 11
 ORS portion 0.3 73 22 57 17
 Liquid other NA 18 NA 30 NA
 ORS nasogastric tube 28.2 17 479 9 254
 IV rehydration 5.0 0 5 2 10
Follow-up/hospitalization
 Hospitalization patients × (LOS days) 575 10 × 2 11,500 7 × 2 8050
 Outpatient clinic 129 25 3225 26 3354
 Telephonic follow-up 20 21 420 15 300
Costs of missed diagnoses/adverse events
 Revisit ED 144 30 4464 30 4320
 Admission after revisit (LOS days × patients) 575 2 × 1 1150 2 × 4 4600
 Mean costs per patient (including CDSS) 408 350
 Mean costs per patient (without CDSS) 346 350

Currency rate EUR/USD 1.11; 8th Nov 2016

LOS length of stay